Author

Xavier Roblin 1

1 university of saint etienne

: THERAPEUTIC DRUG MONITORING OF INFLIXIMAB AND MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY

Stéphane Paul, hubert marotte, Emilie Del Tedesco, Laurent Peyrin-Biroulet, Xavier Roblin

A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY AND SAFETY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet, Alessandro Armuzzi, Raja Atreya, Silvio Danese, Jordi Guardiola, Jørgen Jahnsen, Charlie Lees, Edouard Louis, Milan Lukas, Walter Reinisch, Xavier Roblin, Minyoung Jang, Han Geul Byun

ACUTE INFUSION REACTIONS UNDER VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS: RESULTS OF A MULTICENTER RETROSPECTIVE OBSERVATIONAL COHORT STUDY

chloé Venturin, Stéphane Nancey, Xavier Roblin, Laurent Peyrin-Biroulet, Nicolas Mathieu, Claire Gay, Pauline Danion, Remi Duclaux-Loras, Camille Meunier, Bernard Flourie, Gilles Boschetti

Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre prospective, observational cohort study

Guillaume Pineton de Chambrun, Benjamin Pariente, Philippe Seksik, Romain Altwegg, Lucine Vuitton, Carmen Stefanescu, Stéphane Nancey, Alexandre Aubourg, Mélanie Serrero, Laurent Peyrin-Biroulet, Jerome Filippi, Stéphanie Viennot, Vered Abitbol, Medina Boualit, Arnaud Bourreille, Maria Nachury, Jacques Moreau, Anthony Buis

ANTI-USTEKINUMAB ANTIBODIES USING A DRUG TOLERANT ASSAY IS THE ONLY PREDICTIVE FACTOR OF CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENT UNDER USTEKINUMAB

Xavier Roblin

ANTI-USTEKINUMAB ANTIBODIES USING A DRUG TOLERANT ASSAY IS THE ONLY PREDICTIVE FACTOR OF CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENT UNDER USTEKINUMAB

Narjous CHAWKI, Mohammad CHAWKI, Pierre Cixous, Pauline Veyrard, Anne Berger, Jean Marc Phelip, Stéphane Paul, Xavier Roblin

Assessment of IBD-disk in a prospective multicenter cohort of patients with inflammatory bowel disease

Sara Tadbiri, Maria Nachury, Mélanie Serrero, Yoram Bouhnik, Jerome Filippi, Xavier Roblin, Anne Bourrier, Guillaume Bouguen, Denis Franchimont, Guillaume Savoye, Anthony Buisson, Edouard Louis, Stéphane Nancey, Vered Abitbol, Jean-Marie Reimund, Olivier Dewit, Lucine Vuitton, David Laharie, Aurelien Amiot

ASSOCIATION BETWEEN THIOPURINES METABOLITES LEVELS AND CLINICAL REMISSION IN IBD PATIENTS : AN UPDATED META-ANALYSIS

amelie moreau, silvy laporte, Emilie Del Tedesco, Stéphane Paul, Jean Marc Phelip, Laurent Peyrin-Biroulet, Xavier Roblin

AZATHIOPRINE DOSE REDUCTION  INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A PROSPECTIVE STUDY

Emilie Del Tedesco, Stéphane Paul, hubert marotte, Nicolas Williet, Jean Marc Phelip, Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Xavier Roblin

BASELINE ALBUMIN LEVEL IS NOT A SIGNIFICANT PREDICTOR OF TOFACITINIB EFFICACY IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS OF MULTIVARIATE EXPOSURE-RESPONSE ANALYSIS

Gary R. Lichtenstein, Andrew Tinsley, Xavier Roblin, Tadakazu Hisamatsu, Camille Vong, Shinichi Tsuchiwata, Konstantinos Tsilkos, Haiying Zhang, Arnab Mukherjee, Chinyu Su, David T. Rubin

Item 1 - 10 / 86
1
2 3 4 5 6 7 8 9